HAESEON CHO: Open Payments
NPI 1528460045 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 23 payments from 10 companies in 2025. Trend: 2023 $196 · 2024 $338 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $101 |
| Travere Therapeutics, Inc. | 9 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| Fresenius USA Marketing, Inc. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Novo Nordisk Inc | 1 | $15 |
| Ardelyx, Inc. | 1 | $15 |
| Calliditas Therapeutics US Inc. | 1 | $14 |
Products named: KRYSTEXXA, Kerendia, VELPHORO, FARXIGA, Vanrafia, JYNARQUE, Ozempic, IBSRELA.
Industry payments across GA — which companies pay providers there.
